The pervasive association between political ideology and COVID-19 vaccine uptake in Brazil: an ecologic study

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Citação
BMC PUBLIC HEALTH, v.23, n.1, article ID 1606, 8p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Despite the unequivocal benefits of vaccination, vaccine coverage has been falling in several countries in the past few years. Studies suggest that vaccine hesitancy is an increasingly significant phenomenon affecting adherence to vaccines. More recently, during the COVID-19 pandemic, political views have emerged as an additional influencing factor for vaccine hesitancy.Methods In this ecologic study, we used information from publicly available databases to investigate the association between political ideology, depicted by the percentage of votes for the right-wing candidate Jair Bolsonaro in the presidential elections of 2018 and 2022, and COVID-19 vaccination in Brazilian municipalities. The primary endpoint was the COVID-19 vaccination index, calculated as the number of COVID-19 vaccine doses administered up to September 2022 divided by the number of inhabitants in each municipality. The analysis was conducted using Pearson correlation coefficients and linear regression models adjusted for HDI, the percentage of male voters, the percentage of voters who were older than 50 years old, and the percentage of voters with a middle school education or less. In addition, we explored whether the effect of the percentage of Bolsonaro voters on the COVID-19 vaccination index was modified in different quartiles of HDI using an interaction term.Results Five thousand five hundred sixty-three Brazilian municipalities were included in the analysis. For both the 2018 and 2022 elections, the percentage of votes for Jair Bolsonaro was significantly and inversely associated with COVID-19 vaccine uptake after adjustment for the sociodemographic characteristics of the voters (change in mean vaccination index in 2018 for each 1% increase in Bolsonaro voters-0.11, 95% confidence interval [CI]-0.13 to-0.08, p < 0.001; change in mean vaccination index in 2022 for each 1% increase in Bolsonaro voters-0.09, 95% CI-0.11 to-0.07, p < 0.001). We also found a statistically significant interaction between the primary predictor of interest and HDI scores, with a more significantly detrimental effect of the right-wing political stance in municipalities in the lower HDI quartiles (interaction p < 0.001 for the first HDI quartile; p = 0.001 for the second HDI quartile).Conclusion Our findings suggest that political ideologies have influenced COVID-19 vaccine hesitancy in Brazilian municipalities, affecting communities inequitably. The politicization of vaccines is a new challenge for vaccine programs. Strategies to face these challenges should include joint efforts from governments and civil society for a common public health goal.
Palavras-chave
COVID-19, COVID-19 vaccines, Vaccination hesitancy, Politics, Socioeconomic factors, Mass vaccination, Human development, Political factors, Health policy, Public health
Referências
  1. Ajzenman N., 2020, Cambridge Working Papers in Economics, 2034, DOI 10.2139/SSRN.3582908
  2. Albrecht D, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-021-12432-x
  3. Domingues CMAS, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00222919
  4. Barbieri CLA, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005149
  5. [Anonymous], 2020, BBC News
  6. [Anonymous], 2020, Bloomberg.com
  7. [Anonymous], 2021, Carta Cap
  8. Azanaw J, 2023, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.1001423
  9. Barata RB, 2012, J EPIDEMIOL COMMUN H, V66, P934, DOI 10.1136/jech-2011-200341
  10. Barbara Vanessa, 2021, N.Y. TIMES
  11. Bolsonaro sobre vacina de Pfizer, Se voce virar um jacare, e problema de voce'-18/12/2020-UOL Noticias
  12. Bosco E, 2022, A America Latina frente ao Governo da COVID-19: desigualdades, crises, resistencia
  13. Brown AL, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00011618, 10.1590/0102-311x00011618]
  14. Paschoalotto MAC, 2021, REV SAUDE PUBL, V55, DOI 10.11606/s1518-8787.2021055003903
  15. Césare N, 2020, INT J INFECT DIS, V98, P275, DOI 10.1016/j.ijid.2020.06.092
  16. Cortes G, O Estado Paulo
  17. Daniels JP, 2021, LANCET, V397, P361, DOI 10.1016/S0140-6736(21)00181-1
  18. de Moraes JC, 2003, Epidemiol E Servicos Saude, V12, DOI [10.5123/S1679-49742003000300005, DOI 10.5123/S1679-49742003000300005]
  19. Matos CCDA, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054003042
  20. Domingues CMAS, 2013, EPIDEMIOL SERV SAUDE, V22, P9, DOI 10.5123/S1679-49742013000100002
  21. Fernandez M, 2022, LANCET REG HEALTH-AM, V8, DOI 10.1016/j.lana.2022.100246
  22. da Fonseca EM, 2021, GLOB PUBLIC HEALTH, V16, P1251, DOI 10.1080/17441692.2021.1945123
  23. Gowda C, 2013, HUM VACC IMMUNOTHER, V9, P1755, DOI 10.4161/hv.25085
  24. Gramacho WG, 2021, VACCINE, V39, P2608, DOI 10.1016/j.vaccine.2021.03.080
  25. Guglielmi G, 2022, NATURE, V608, P253, DOI 10.1038/d41586-022-02051-w
  26. Gullino D, 2021, O Globo
  27. Haberman M., 2021, N. Y. Times
  28. Hallal PC, 2021, LANCET, V397, P373, DOI 10.1016/S0140-6736(21)00141-0
  29. Hassan W., 2021, NARRA J, V1, DOI [10.52225/narra.v1i3.57, DOI 10.52225/NARRA.V1I3.57]
  30. Hochman G., 2011, Cienc Saude Coletiva, V16, P375, DOI [10.1590/S1413-81232011000200002, DOI 10.1590/S1413-81232011000200002]
  31. ibge, Estimativas da populacao residente para os municipios e para as unidades da federacao
  32. Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081
  33. Leuchter RK, 2022, NEW ENGL J MED, V386, P2531, DOI 10.1056/NEJMc2204560
  34. MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
  35. Makarenko C, 2022, REV SAUDE PUBL, V56, DOI 10.11606/s1518-8787.2022056003805
  36. Martins L, Mesmo dizendo que liberou acesso, Bolsonaro mantem sigilo de sua vacinacao
  37. Martins-Filho PR, 2022, LANCET REG HEALTH-AM, V8, DOI 10.1016/j.lana.2022.100206
  38. Mengistu DA, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.1044193
  39. Moghadas SM, 2021, CLIN INFECT DIS, V73, P2257, DOI 10.1093/cid/ciab079
  40. Murakawa F, Valor Economico
  41. paho, COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades-PAHO/WHO
  42. Razai MS, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1138
  43. Romano JO, Monde Dipl. Bras
  44. Sato APS, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052001199, 10.11606/s1518-8787.2018052001199]
  45. SeyedAlinaghi S, 2022, HEALTH SCI REP-US, V5, DOI 10.1002/hsr2.516
  46. Siddiqui M, 2013, HUM VACC IMMUNOTHER, V9, P2643, DOI 10.4161/hv.27243
  47. Silveira MM, 2021, J MED MICROBIOL, V70, DOI 10.1099/jmm.0.001466
  48. Silveira MF, 2020, VACCINE, V38, P482, DOI 10.1016/j.vaccine.2019.10.070
  49. Teixeira CF, 2023, CIENC SAUDE COLETIVA, V28, P1277, DOI [10.1590/1413-81232023285.10502022EN, 10.1590/1413-81232023285.10502022]
  50. Temporão José Gomes, 2003, Hist. cienc. saude-Manguinhos, V10, P601, DOI 10.1590/S0104-59702003000500008
  51. tse, SIG Eleicao-Resultados
  52. washingtonpost, Wash. Post
  53. Xavier DR, 2022, LANCET REG HEALTH-AM, V10, DOI 10.1016/j.lana.2022.100221